Jordan Gainey
Overview
Explore the profile of Jordan Gainey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan Q, Bowar B, Ismael H, Gainey J, Myers B, Dlouhy B, et al.
Adv Radiat Oncol
. 2024 May;
9(4):101440.
PMID: 38778828
Purpose: Pediatric low-grade tectal gliomas are rare, indolent tumors of the brain stem. We reviewed outcomes of pediatric patients who received a diagnosis of low-grade tectal gliomas and report dosimetric...
2.
Khan Q, Bowar B, Myers B, Kenjar F, Byrne J, Gainey J
Adv Radiat Oncol
. 2024 Apr;
9(5):101452.
PMID: 38590715
Purpose: An effective didactic curriculum is a cornerstone for a successful residency program, as it is the basis upon which residents acquire the necessary knowledge and perspective to provide high-quality,...
3.
Khan Q, Myers B, Bowar B, Khan M, Mullaney H, Gainey J, et al.
Front Oncol
. 2024 Feb;
13:1284688.
PMID: 38313211
Background: Peritoneal carcinomatosis is a particularly rare presentation of prostate cancer. Here we report a rare clinical case of surgically identified peritoneal carcinomatosis at the time of a planned robotic...
4.
Sperduto P, De B, Li J, Carpenter D, Kirkpatrick J, Milligan M, et al.
Int J Radiat Oncol Biol Phys
. 2022 Mar;
114(1):60-74.
PMID: 35331827
Purpose: Patients with lung cancer and brain metastases represent a markedly heterogeneous population. Accurate prognosis is essential to optimally individualize care. In prior publications, we described the graded prognostic assessment...
5.
Nathaniel T, Ubah C, Wormack L, Gainey J
Diabetol Metab Syndr
. 2019 May;
11:36.
PMID: 31086570
Objective: Several controversial findings have been reported on treatment outcomes for diabetic stroke patients that received thrombolysis therapy in the hospital. We determined whether the association between telestroke technology, thrombolysis...
6.
Brecthel L, Gainey J, Penwell A, Nathaniel T
BMC Neurol
. 2018 Dec;
18(1):215.
PMID: 30577762
Background: In acute ischemic stroke patients, telestroke technology provides sustainable approaches to improve the use of thrombolysis therapy. How this is achieved as it relates to inclusion or exclusion of...
7.
Gainey J, Blum B, Bowie B, Cooley K, Madeline L, Ervin E, et al.
Lipids Health Dis
. 2018 Sep;
17(1):226.
PMID: 30261884
Background: Clinical risk factors related to not administering thrombolysis to acute ischemic stroke patients with incidence dyslipidemia is not clear. This issue was investigated in telestroke and non-telestroke settings. Methods:...
8.
Gainey J, Brecthtel L, Blum B, Keels A, Madeline L, Lowther E, et al.
J Exp Neurosci
. 2018 Sep;
12:1179069518793412.
PMID: 30245570
The efficiency of telestroke programs in improving the rates of recombinant tissue plasminogen activator (rtPA) in stroke patients has been reported. Previous studies have reported favorable treatment outcomes with the...
9.
Nathaniel T, Gainey J, Blum B, Montgomery C, Ervin L, Madeline L
J Stroke Cerebrovasc Dis
. 2018 Jun;
27(9):2524-2533.
PMID: 29859864
Background: The objective of this study is to determine clinical risk factors associated with exclusion from thrombolysis in telestroke and nontelestroke settings. These risk factors may offer clues for optimization...
10.
Gainey J, Brechtel L, Konklin S, Madeline L, Lowther E, Blum B, et al.
J Neurol Sci
. 2018 Mar;
387:139-146.
PMID: 29571851
Background: The treatment outcomes in the use of rt-PA have been reported. Some studies reported worse outcome in women than men, while others presented opposing data. Using data from a...